A mathematical or computational model of infectious disease transmission represents the process of how an infection spreads from one person to another. Such models have a long history within infectious disease epidemiology, and are useful tools for giving insight into the dynamics of epidemics and for evaluating the potential effect of control methods. The overall objective of this project is to substantially improve the methods by which models of infectious diseases transmission are calibrated against biological and disease surveillance data. This will both improve the utility of models as tools for analyzing data on infectious disease outbreaks (for instance to provide more rapid and reliable estimates of how transmissible and lethal a new virus is to public health agencies) and also improve the reliability of models as tools for predicting the likely effect of different interventions (such as vaccines or case isolation) to help policy makers make more informed decisions about control policies. As with many areas of biology and medicine, the data landscape for infectious diseases modeling is changing rapidly. Larger and more complex datasets are becoming available that cover many different aspects of the interaction between a pathogen and the human population: clinical episode data, genetic data about fast-evolving pathogens; animal-model transmission data and community-based representative serological data.
The specific aims of our project are to: (a) develop new machine-learning based methods to discover interesting patterns in complex datasets related to the transmission of infectious disease, so as to better specify subsequent mechanistic mathematical or computational models; (b) derive new approaches for using more than one type of data simultaneously to calibrate transmission models and (c) derive new methods of parameter estimation for simulations which model the spatial spread of infection or model both the transmission and genetic evolution of a pathogen. We will achieve these aims in the applied context of research on three key infections: emerging infectious diseases (such as MERS-CoV - the novel coronavirus currently spreading in the Middle East), influenza and Streptococcus pneumonia (a major bacterial pathogen). Examples of the scientific questions we will address that cannot be answered with current methods are: (i) how many unobserved cases of MERS-CoV have occurred so far (to be answered using data on case clusters data, the spatial distribution of cases and viral genetic sequences)? (ii) how many people in different age groups are infected with influenza each year and how does their immune system respond to infection (to be answered using data on case incidence and serological testing of the population)? (iii) how much is vaccination coupled with prescribing practices influencing the emergence of resistant strains of pneumococcus (to be addressed with data on antibiotic and vaccine use, case incidence and bacterial strain frequency)?

Public Health Relevance

Mathematical and computational models of infectious disease spread can provide valuable information to aid policy-makers in the tough choices they face when trying to control infectious diseases, but models must be designed to make the best possible use of the often limited data available. As the digital footprints of our lives grow, so te datasets available for infectious disease models become larger and more complex. This project will develop new algorithms and methods to allow models to make better use of all available data and therefore better inform control policy planning for diseases such as: influenza, pneumococcal infection and novel viruses like MERS-CoV.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01GM110721-03
Application #
9099895
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Janes, Daniel E
Project Start
2014-09-15
Project End
2019-05-31
Budget Start
2016-06-01
Budget End
2017-05-31
Support Year
3
Fiscal Year
2016
Total Cost
Indirect Cost
Name
U of L Imperial Col of Sci/Technlgy/Med
Department
Type
DUNS #
227092590
City
London
State
Country
United Kingdom
Zip Code
SW7 2AZ
Kwok, Kin On; Read, Jonathan M; Tang, Arthur et al. (2018) A systematic review of transmission dynamic studies of methicillin-resistant Staphylococcus aureus in non-hospital residential facilities. BMC Infect Dis 18:188
Dorigatti, Ilaria; McCormack, Clare; Nedjati-Gilani, Gemma et al. (2018) Using Wolbachia for Dengue Control: Insights from Modelling. Trends Parasitol 34:102-113
Wei, Vivian W I; Wong, Jessica Y T; Perera, Ranawaka A P M et al. (2018) Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015. PLoS One 13:e0197504
Wong, Jonathan Wh; Ip, Margaret; Tang, Arthur et al. (2018) Prevalence and risk factors of community-associated methicillin-resistant Staphylococcus aureus carriage in Asia-Pacific region from 2000 to 2016: a systematic review and meta-analysis. Clin Epidemiol 10:1489-1501
Campbell, Finlay; Strang, Camilla; Ferguson, Neil et al. (2018) When are pathogen genome sequences informative of transmission events? PLoS Pathog 14:e1006885
Nouvellet, Pierre; Cori, Anne; Garske, Tini et al. (2018) A simple approach to measure transmissibility and forecast incidence. Epidemics 22:29-35
Dorigatti, Ilaria; Hamlet, Arran; Aguas, Ricardo et al. (2017) International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017. Euro Surveill 22:
Nikolay, Birgit; Salje, Henrik; Sturm-Ramirez, Katharine et al. (2017) Evaluating Hospital-Based Surveillance for Outbreak Detection in Bangladesh: Analysis of Healthcare Utilization Data. PLoS Med 14:e1002218
Cori, Anne; Donnelly, Christl A; Dorigatti, Ilaria et al. (2017) Key data for outbreak evaluation: building on the Ebola experience. Philos Trans R Soc Lond B Biol Sci 372:
Cobey, Sarah; Baskerville, Edward B; Colijn, Caroline et al. (2017) Host population structure and treatment frequency maintain balancing selection on drug resistance. J R Soc Interface 14:

Showing the most recent 10 out of 78 publications